Protocol ID |
Official Title |
Principal Investigator |
Contact |
Disease Site? |
Phase? |
| NLG-2105 ClinicalTrials.gov: NCT02502708 |
Phase 1 Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors |
T. Johnson | Robin Dobbins & Kimberly Gray |
Brain Tumor | I |
| NMTRC014 ClinicalTrials.gov: NCT02679144 |
NMTT - Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO); NMTRC014 |
C. McDonough | Kimberly Gray | Neuroblastoma | II |
|
AHOD1331 ClinicalTrials.gov: NCT02166463 |
A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents Protocol | C. McDonough | Robin Dobbins & Kimberly Gray |
Classical Hodgkin Lymphoma | III |
